tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adma Biologics affirms 2025 revenue outlook over $500M, consensus $505.83M
PremiumThe FlyAdma Biologics affirms 2025 revenue outlook over $500M, consensus $505.83M
2M ago
Adma Biologics sees 2026 revenue $625M or more, consensus $637.28M
Premium
The Fly
Adma Biologics sees 2026 revenue $625M or more, consensus $637.28M
2M ago
ADMA Biologics Inc. Warns Investors of Significant Business Risks in Latest Report
Premium
Company Announcements
ADMA Biologics Inc. Warns Investors of Significant Business Risks in Latest Report
2M ago
ADMA Biologics Reports Strong Q1 2025 Financial Growth
PremiumCompany AnnouncementsADMA Biologics Reports Strong Q1 2025 Financial Growth
5M ago
ADMA Biologics Announces $500M Share Repurchase Program
Premium
Company Announcements
ADMA Biologics Announces $500M Share Repurchase Program
5M ago
Adma Biologics options imply 10.9% move in share price post-earnings
Premium
The Fly
Adma Biologics options imply 10.9% move in share price post-earnings
5M ago
ADMA Biologics reiterates ‘strategic advantage’ through U.S.-based manufacturing
PremiumThe FlyADMA Biologics reiterates ‘strategic advantage’ through U.S.-based manufacturing
6M ago
ADMA Biologics: Strong Growth Prospects and Stability Drive Buy Rating
Premium
Ratings
ADMA Biologics: Strong Growth Prospects and Stability Drive Buy Rating
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100